Ryan McDonald

Articles

Medical Marijuana May Reduce Common Chemotherapy AEs; More Research Needed

April 21, 2021

Data presented at the Oncology Nursing Society’s 46th Annual Congress demonstrates that there is low level evidence that suggests medical marijuana or cannabinoids may reduce chemotherapy-related adverse events in patients with cancer.

Mental Health Screening Is Needed in Blood Cancer Space

December 26, 2020

Data from a recent analysis demonstrated that more than one in five people experienced depression or anxiety, either before or not long after receiving a blood cancer diagnosis, highlighting the need for further mental health screening in these individuals.

FDA Update on Breast Implant-Associated Lymphoma, Breast Implant Illness

August 24, 2020

The Food and Drug Administration (FDA) provided an update on breast-implant associated side effects that have been reported to the agency, including breast implant-associated anaplastic large cell lymphoma (BI-ALCL) and symptoms that are commonly referred to by patients as breast implant illness (BII).

High Body Weight Shows Trend Toward Improved Myeloma Outcomes

July 27, 2020

Patients with multiple myeloma who were obese or overweight had a trend toward slightly improved progression-free survival and overall survival outcomes compared to patients who had a normal weight, according to data from an exploratory analysis.

Extraordinary Healer Emcee, Kathy LaTour, Is Remembered Fondly

July 06, 2020

LaTour was the emcee for the Extraordinary Healer Award Dinner, which honors the work of oncology nurses and is hosted every year at the Oncology Nursing Society Annual Congress. She was also a co-founder of CURE Magazine, as well as an author and breast cancer survivor. She died on June 19.

Acalabrutinib Shows Promise for Frontline CLL Treatment

June 08, 2020

Long-term data presented at the 2020 ASCO Virtual Scientific Program demonstrated that acalabrutinib (Calquence) is safe and effective in patients with treatment-naïve chronic lymphocytic leukemia, supporting its use in the front line setting in this population.